APO RESEARCH · REPORT
Humira
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Product & engineering
Understand the product.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
Selected research
Industry Research
Humira Industry Research Report 2026
Market perspective
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Read the full market overview
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Report Scope
This report quantifies the global Humira market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Humira Market by Company
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Humira Segment by Type
Humira Syringe
Humira Pen
Humira Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
Humira Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Humira market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Humira and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Humira.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Humira manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Humira by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Humira in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Humira Syringe
- Humira Pen
Applications
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Others
Companies covered
- AbbVie
- Eisai
- Cadila Healthcare
- Torrent Pharmaceuticals
- Amgen
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Humira Market Size (2021-2032)
- 2.2.2 Global Humira Sales (2021-2032)
- 2.2.3 Global Humira Market Average Price (2021-2032)
- 2.3 Humira by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Humira Syringe
- 2.3.3 Humira Pen
- 2.4 Humira by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ankylosing Spondylitis
- 2.4.3 Rheumatoid Arthritis
- 2.4.4 Crohn’s Disease
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Humira Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Humira Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Humira Revenue of Manufacturers (2021-2026)
- 3.4 Global Humira Average Price by Manufacturers (2021-2026)
- 3.5 Global Humira Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Humira, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Humira, Product Type & Application
- 3.8 Global Manufacturers of Humira, Established Date
- 3.9 Global Humira Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AbbVie
- 4.1.1 AbbVie Company Information
- 4.1.2 AbbVie Business Overview
- 4.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AbbVie Humira Product Portfolio
- 4.1.5 AbbVie Recent Developments
- 4.2 Eisai
- 4.2.1 Eisai Company Information
- 4.2.2 Eisai Business Overview
- 4.2.3 Eisai Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eisai Humira Product Portfolio
- 4.2.5 Eisai Recent Developments
- 4.3 Cadila Healthcare
- 4.3.1 Cadila Healthcare Company Information
- 4.3.2 Cadila Healthcare Business Overview
- 4.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cadila Healthcare Humira Product Portfolio
- 4.3.5 Cadila Healthcare Recent Developments
- 4.4 Torrent Pharmaceuticals
- 4.4.1 Torrent Pharmaceuticals Company Information
- 4.4.2 Torrent Pharmaceuticals Business Overview
- 4.4.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Torrent Pharmaceuticals Humira Product Portfolio
- 4.4.5 Torrent Pharmaceuticals Recent Developments
- 4.5 Amgen
- 4.5.1 Amgen Company Information
- 4.5.2 Amgen Business Overview
- 4.5.3 Amgen Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amgen Humira Product Portfolio
- 4.5.5 Amgen Recent Developments
- 4.6 Boehringer Ingelheim
- 4.6.1 Boehringer Ingelheim Company Information
- 4.6.2 Boehringer Ingelheim Business Overview
- 4.6.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Boehringer Ingelheim Humira Product Portfolio
- 4.6.5 Boehringer Ingelheim Recent Developments
5 Global Humira Market Scenario by Region
- 5.1 Global Humira Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Humira Sales by Region: 2021-2032
- 5.2.1 Global Humira Sales by Region: 2021-2026
- 5.2.2 Global Humira Sales by Region: 2027-2032
- 5.3 Global Humira Revenue by Region: 2021-2032
- 5.3.1 Global Humira Revenue by Region: 2021-2026
- 5.3.2 Global Humira Revenue by Region: 2027-2032
- 5.4 North America Humira Market Facts & Figures by Country
- 5.4.1 North America Humira Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Humira Sales by Country (2021-2032)
- 5.4.3 North America Humira Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Humira Market Facts & Figures by Country
- 5.5.1 Europe Humira Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Humira Sales by Country (2021-2032)
- 5.5.3 Europe Humira Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Humira Market Facts & Figures by Country
- 5.6.1 Asia Pacific Humira Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Humira Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Humira Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Humira Market Facts & Figures by Country
- 5.7.1 South America Humira Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Humira Sales by Country (2021-2032)
- 5.7.3 South America Humira Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Humira Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Humira Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Humira Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Humira Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Humira Sales by Type (2021-2032)
- 6.1.1 Global Humira Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Humira Sales Market Share by Type (2021-2032)
- 6.2 Global Humira Revenue by Type (2021-2032)
- 6.2.1 Global Humira Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Humira Revenue Market Share by Type (2021-2032)
- 6.3 Global Humira Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Humira Sales by Application (2021-2032)
- 7.1.1 Global Humira Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Humira Sales Market Share by Application (2021-2032)
- 7.2 Global Humira Revenue by Application (2021-2032)
- 7.2.1 Global Humira Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Humira Revenue Market Share by Application (2021-2032)
- 7.3 Global Humira Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Humira Value Chain Analysis
- 8.1.1 Humira Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Humira Production Mode & Process
- 8.2 Humira Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Humira Distributors
- 8.2.3 Humira Customers
9 Global Humira Analyzing Market Dynamics
- 9.1 Humira Industry Trends
- 9.2 Humira Industry Drivers
- 9.3 Humira Industry Opportunities and Challenges
- 9.4 Humira Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst